Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$97.40
-0.2%
$90.62
$67.27
▼
$98.38
$419.74B0.2818.83 million shs13.84 million shs
Realty Income Corporation stock logo
O
Realty Income
$59.26
-0.5%
$56.94
$53.15
▼
$67.93
$56.65B0.656.96 million shs5.72 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.86
-2.0%
$28.80
$23.62
▼
$31.44
$167.86B0.3135.68 million shs30.74 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Coca-Cola Company (The) stock logo
KO
Coca-Cola
+0.67%+1.57%+8.79%+11.44%+36.31%
Realty Income Corporation stock logo
O
Realty Income
+0.06%+0.58%+9.01%-5.48%+4.27%
Pfizer Inc. stock logo
PFE
Pfizer
+0.33%-4.47%+3.62%+9.75%+15.41%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$97.40
-0.2%
$90.62
$67.27
▼
$98.38
$419.74B0.2818.83 million shs13.84 million shs
Realty Income Corporation stock logo
O
Realty Income
$59.26
-0.5%
$56.94
$53.15
▼
$67.93
$56.65B0.656.96 million shs5.72 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$28.86
-2.0%
$28.80
$23.62
▼
$31.44
$167.86B0.3135.68 million shs30.74 million shs
7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Coca-Cola Company (The) stock logo
KO
Coca-Cola
+0.67%+1.57%+8.79%+11.44%+36.31%
Realty Income Corporation stock logo
O
Realty Income
+0.06%+0.58%+9.01%-5.48%+4.27%
Pfizer Inc. stock logo
PFE
Pfizer
+0.33%-4.47%+3.62%+9.75%+15.41%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Coca-Cola Company (The) stock logo
KO
Coca-Cola
2.92
Moderate Buy$97.26-0.15% Downside
Realty Income Corporation stock logo
O
Realty Income
2.44
Hold$71.6920.97% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.18
Hold$30.325.05% Upside

Current Analyst Ratings Breakdown

Latest KO, O, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
Pfizer Inc. stock logo
PFE
Pfizer
Reiterated RatingMarket Perform$29.00
11/10/2026
Realty Income Corporation stock logo
O
Realty Income
Boost Price TargetHold$60.00 ➝ $63.00
11/9/2026
Pfizer Inc. stock logo
PFE
Pfizer
UpgradeHold (C) ➝ Hold (C+)
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$33.00 ➝ $34.00
11/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
DowngradeBuy ➝ Hold
11/5/2026
Realty Income Corporation stock logo
O
Realty Income
Lower Price TargetNeutral$68.00 ➝ $63.00
11/5/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetBuy$31.00 ➝ $33.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Set Price Target$40.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetNeutral$27.00 ➝ $30.00
11/4/2026
Pfizer Inc. stock logo
PFE
Pfizer
Boost Price TargetSector Outperform$33.00 ➝ $35.00
(Data available from 11/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$47.94B8.74$3.25 per share29.94$9.19 per share10.60
Realty Income Corporation stock logo
O
Realty Income
$5.75B9.80$3.95 per share15.01$44.80 per share1.32
Pfizer Inc. stock logo
PFE
Pfizer
$62.58B2.63$4.31 per share6.70$15.67 per share1.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$13.11B$3.4029.3927.593.8128.65%38.79%13.50%N/A
Realty Income Corporation stock logo
O
Realty Income
$1.06B$1.4513.4812.944.3321.85%3.27%1.80%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$7.77B$0.709.669.751.946.34%19.88%8.52%N/A

Latest KO, O, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026
Pfizer Inc. stock logo
PFE
Pfizer
$0.7350$0.87+$0.1350$0.56$15.85 billion$16.58 billion
11/2/2026Q3 2026
Realty Income Corporation stock logo
O
Realty Income
$0.4068$0.43+$0.0232$0.43$1.43 billion$1.62 billion
10/27/2026Q3 2026
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$0.8810$0.91+$0.0290$0.93$12.92 billion$13.35 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Coca-Cola Company (The) stock logo
KO
Coca-Cola
$2.122.18%+4.46%62.35%64 Years
Realty Income Corporation stock logo
O
Realty Income
$3.265.50%+4.50%224.83%31 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.725.96%-13.20%245.71%16 Years

Latest KO, O, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
10/15/2026
Coca-Cola Company (The) stock logo
KO
Coca-Cola
quarterly$0.532.31%12/1/202612/1/202612/15/2026
11/10/2026
Realty Income Corporation stock logo
O
Realty Income
monthly$0.27405.52%11/30/202611/30/202612/15/2026
10/6/2026
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.435.85%11/6/202611/6/202612/7/2026
10/13/2026
Realty Income Corporation stock logo
O
Realty Income
monthly$0.27155.72%10/30/202610/30/202611/13/2026
9/8/2026
Realty Income Corporation stock logo
O
Realty Income
monthly$0.27156%9/30/20269/30/202610/15/2026
8/18/2026
Realty Income Corporation stock logo
O
Realty Income
monthly$0.27105.3%8/31/20268/31/20269/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Coca-Cola Company (The) stock logo
KO
Coca-Cola
0.93
1.38
1.19
Realty Income Corporation stock logo
O
Realty Income
0.74
6.04
6.04
Pfizer Inc. stock logo
PFE
Pfizer
0.67
1.42
1.10

Institutional Ownership

CompanyInstitutional Ownership
Coca-Cola Company (The) stock logo
KO
Coca-Cola
70.26%
Realty Income Corporation stock logo
O
Realty Income
70.81%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Coca-Cola Company (The) stock logo
KO
Coca-Cola
0.90%
Realty Income Corporation stock logo
O
Realty Income
0.10%
Pfizer Inc. stock logo
PFE
Pfizer
0.62%
CompanyEmployeesShares OutstandingFree FloatOptionable
Coca-Cola Company (The) stock logo
KO
Coca-Cola
65,9004.30 billion4.26 billionOptionable
Realty Income Corporation stock logo
O
Realty Income
544951.00 million950.05 millionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
75,0005.70 billion5.66 billionOptionable

Recent News About These Companies

Pfizer to stop selling Premarin hormone therapy in Canada
Pfizer Secures Up to $1.5B Funding From Blackstone for Obesity Program
Pfizer, Blackstone in $1.5B deal for obesity drug program
Pfizer, Blackstone Agree to Fund Obesity Program

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Coca-Cola stock logo

Coca-Cola NYSE:KO

$97.40 -0.17 (-0.17%)
Closing price 03:59 PM Eastern
Extended Trading
$97.38 -0.02 (-0.02%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Coca-Cola Company, a beverage company, manufactures, markets, and sells various nonalcoholic beverages worldwide. The company provides sparkling soft drinks, sparkling flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and other beverages. It also offers beverage concentrates and syrups, as well as fountain syrups to fountain retailers, such as restaurants and convenience stores. The company sells its products under the Coca-Cola, Diet Coke/Coca-Cola Light, Coca-Cola Zero Sugar, caffeine free Diet Coke, Cherry Coke, Fanta Orange, Fanta Zero Orange, Fanta Zero Sugar, Fanta Apple, Sprite, Sprite Zero Sugar, Simply Orange, Simply Apple, Simply Grapefruit, Fresca, Schweppes, Thums Up, Aquarius, Ayataka, BODYARMOR, Ciel, Costa, Dasani, dogadan, FUZE TEA, Georgia, glacéau smartwater, glacéau vitaminwater, Gold Peak, Ice Dew, I LOHAS, Powerade, Topo Chico, AdeS, Del Valle, fairlife, innocent, Minute Maid, and Minute Maid Pulpy brands. It operates through a network of independent bottling partners, distributors, wholesalers, and retailers, as well as through bottling and distribution operators. The company was founded in 1886 and is headquartered in Atlanta, Georgia.

Realty Income stock logo

Realty Income NYSE:O

$59.26 -0.31 (-0.52%)
Closing price 03:59 PM Eastern
Extended Trading
$59.20 -0.06 (-0.10%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a real estate investment trust ("REIT"), and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 644 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 123 times since Realty Income's public listing in 1994 (NYSE: O).

Pfizer stock logo

Pfizer NYSE:PFE

$28.86 -0.59 (-2.01%)
Closing price 03:59 PM Eastern
Extended Trading
$28.88 +0.02 (+0.07%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.